Skip to main content
Clinical Trials/DRKS00023649
DRKS00023649CompletedPhase 4

Assessment of the antiadhesion efficacy of BioRegen® crosslinked hyaluronic acid gel in Laparoscopically Endometriosis Surgery - Pilot study - combination product trial - ACHYLES STUDY”

BioRegen Biomedical (Changzhou) Co., Ltd.0 sites60 target enrollmentStarted: April 17, 2023Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
N/a: Single Arm Study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 55 Years (—)
Sex
Female

Inclusion Criteria

  • Women aged 18-55
  • Women willing, able to and having freely given written consent to participate in the study and abide its requirements.
  • Women in good general health; including ASA (American Society of Anesthesiologists) score of 2 or less.
  • - Women agree to a 3-step therapy for endometriosis
  • - Subject not currently pregnant.
  • Sexually active premenopausal women that agrees to not attempting pregnancy within 3 months after product application and agree to use a method of contraception.

Exclusion Criteria

  • Subjects that meet the main inclusion criteria but attempting to get pregnant within 3 months of product application.
  • Patients must be also excluded if they meet any of the following criteria
  • Current pregnancy including ectopic pregnancy.
  • Concurrent use of systemic corticosteroids, antineoplastic agents and/or radiation.
  • History of cancer within the past 5 years (excluding breast cancer)
  • History of heparin induced thrombocytopenia (HIT), or known sensitivity to heparin-like products.
  • History of blood coagulation disorders
  • Active pelvic or abdominal infection.
  • Additional surgical procedure (non-OB/GYN) planned to be performed during the laparoscopic procedure (excluding appendectomy)
  • Known or suspected allergy to hyaluronic acid

Investigators

Similar Trials